US Stock MarketDetailed Quotes

CLRB Cellectar BioSciences

Watchlist
  • 0.2640
  • -0.0412-13.50%
Close Dec 12 16:00 ET
  • 0.2600
  • -0.0040-1.52%
Pre 06:45 ET
10.90MMarket Cap-0.19P/E (TTM)

About Cellectar BioSciences Company

Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124 which could detect tumors and metastases in a broad range of cancers and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded in June 1996 and is headquartered in Florham Park, NJ.

Company Profile

SymbolCLRB
Company NameCellectar BioSciences
Listing DateAug 15, 2014
Founded1996
CEOMr. James V. Caruso
MarketNASDAQ
Employees20
Fiscal Year Ends12-31
Address100 Campus Drive
CityFlorham Park
ProvinceNew Jersey
CountryUnited States of America
Zip Code07932
Phone1-608-441-8120

Company Executives

  • Name
  • Position
  • Salary
  • James V. Caruso
  • Director, Chief Executive Officer and President
  • 1.97M
  • Shane Lea
  • Chief Commercial Officer
  • --
  • Chad J. Kolean
  • Principal Accounting Officer, Vice President, Secretary and Chief Financial Officer
  • 1.11M
  • Jarrod Longcor
  • Chief Operating Officer
  • 1.36M
  • Andrei Shustov
  • Senior Vice President, Medical
  • --
  • Douglas J Swirsky
  • Chairman of the Board
  • 109.88K
  • Dr. Stefan D. Loren, PhD
  • Independent Director
  • 93.25K
  • John P. Neis
  • Independent Director
  • 93.25K
  • Frederick W. Driscoll
  • Independent Director
  • 93.25K
  • Dr. Asher Chanan-Khan, M.B.B.S.,M.D.
  • Independent Director
  • 48.25K
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.